Abstract: An implantable device for automatic drug administration includes a housing; a drug release unit configured to eject a drug; and a driving unit configured to drive the drug release unit at preset intervals, wherein the drug release unit comprises a drug storage, a drug chamber receiving a drug from the drug storage, and a drug release controller configured to fill the drug chamber with a drug received and release the drug filled in the drug chamber. The drug release controller comprises a plunger configured to form one of positive pressure and negative pressure in the drug chamber as the plunger moves, a plunger spring configured to apply a restoring force to a position where the plunger applies presses the drug chamber, and a gear portion connected to the driving unit and configured to rotate at a preset time to drive the drug release unit.

Abstract: A display device comprises a substrate including a display area including light emission areas, and a non-display area disposed adjacent to the display area, a circuit layer disposed on the substrate, and an element layer disposed on the circuit layer, and including light emitting elements disposed in the light emission areas. The circuit layer includes emission pixel drivers electrically connected to the light emitting elements, and gate lines electrically connected to the emission pixel drivers. The gate lines are disposed in a first gate conductive layer on a first gate insulating layer overlapping a semiconductor layer. The gate lines include first gate lines, each of which includes an extension portion extended to the non-display area and disposed in the non-display area. An extension length of the extension portion is equal to or greater than a width of the emission pixel driver in the first direction.

Abstract: A camera module according to an embodiment of the present invention includes: a lens group; a lens support unit for accommodating the lens group; a magnet arranged on the outer surface of the lens support unit; a yoke portion spaced apart from the magnet and arranged to face the magnet; and a coil arranged on the yoke portion so as to be spaced apart from and to face the magnet between the magnet and the yoke portion, wherein the lens group, the lens support unit, and the magnet move together along an optical axis according to a current applied to the coil, the yoke portion includes a first yoke and a second yoke arranged on the first yoke, the second yoke is arranged between the first yoke and the coil, and magnetism of the first yoke is stronger than that of the second yoke.

Abstract: The present specification relates to a method of preparing a positive electrode active material for a lithium secondary battery, and more particularly, to a positive electrode active material for a lithium secondary battery with excellent electrical conductivity and energy density, a method of preparing the same, and a positive electrode and a secondary battery including the same.

Abstract: The present specification relates to a method of preparing a positive electrode active material for a lithium secondary battery, and more particularly, to a positive electrode active material for a lithium secondary battery with excellent electrical conductivity and energy density, a method of preparing the same, and a positive electrode and a secondary battery including the same.

Abstract: Disclosed in one or more embodiments is a notching device including a die configured to support an electrode, a first stripper configured to move toward the die, and configured to press a mixture portion of the electrode, a second stripper configured to move toward the die, and configured to press an uncoated portion of the electrode, and a pattern portion configured to move toward the die, and configured to form a pattern on the uncoated portion.

Abstract: A biomarker composition for predicting susceptibility to a therapeutic agent for neurofibromatosis by using Ras activity; and a pharmaceutical composition for preventing or treating neurofibromatosis, including a Ras activity inhibitor. The biomarker composition can accurately diagnose susceptibility to a therapeutic agent for neurofibromatosis by measuring the expression levels of a GTP-bound and activated Ras (Ras-GTP) protein and an activated p-ERK protein or a gene encoding the same in a biological sample of an individual. The pharmaceutical composition inhibits the activity of Ras proteins, and thus can be effectively used for the prevention or treatment of neurofibromatosis in which the activity of the Ras proteins is increased.

Abstract: A secondary battery electrode notching apparatus, including a die configured to support a secondary battery electrode including a composite portion coated with an electrode active material and an uncoated portion not coated with the electrode active material; a composite portion stripper configured to move toward the die and press the composite portion into close contact with the die; an uncoated portion stripper configured to move toward the die, press the uncoated portion into close contact with the die, and including an elastic pad formed of an elastic material and configured to elastically deform to make surface contact with the uncoated portion; and a punch configured to move toward the die and cut the uncoated portion so that scrap for disposal is formed from the uncoated portion.

Abstract: Disclosed is a noble metal-manganese oxide composite catalyst for a positive electrode of an aqueous rechargeable battery that can regenerate a solvent of an aqueous electrolyte. Also disclosed are a method for preparing the composite catalyst, a positive electrode for an aqueous rechargeable battery including the composite catalyst, and an aqueous rechargeable battery including the positive electrode. The composite catalyst can regenerate reaction products, including gases continuously generated from spontaneous corrosion of the electrodes or side reactions, back to water to prevent depletion of the electrolyte. Due to this ability, the composite catalyst improves the life characteristics of the battery and suppresses the occurrence of excessive overpotentials at the electrodes. Therefore, the use of the composite catalyst is effective in preventing the performance of the battery from deteriorating.

Abstract: The present invention relates to a composition comprising a CYP4A-inhibiting compound as an active ingredient for preventing or treating metabolic diseases, more specifically to a composition comprising the compound expressed by chemical formula 1 of the present invention or pharmaceutically acceptable salt thereof as an active ingredient for preventing, ameliorating or treating metabolic diseases.

Abstract: Disclosed is an electrochemical device separator including a porous polymer substrate and an organic/inorganic composite porous coating layer formed on at least one side of the polymer substrate, wherein the organic/inorganic composite porous coating layer comprises particulate binder resins and first inorganic particles, the particulate binder polymers include hybrid polymer particles of a fluorine-based polymer and an acrylic-based polymer and acrylic-based polymer particles, the acrylic polymer particles have a particle size D50 “a” in a range of 1 to 7 ?m, the first inorganic particles have a particle size D50 “b” in a range of 200 to 800 nm, a/b is 2 to 15, and the hybrid polymer particles have a particle size D50 smaller than that of the acrylic polymer particles.

Abstract: A coil component includes a body, a support member disposed within the body, a coil disposed on the support member, and including a lower surface in contact with the support member, an upper surface facing the lower surface, an insulating wall covering a side of the coil and filling a gap between respective turns of the coil, an insulating film disposed between adjacent the insulating walls and covering the upper surface of the coil, and an external electrode disposed on the body. The insulating wall includes a plurality of layers, with an interface therebetween. A height of the insulating wall is greater than or equal to a height of an upper surface of the insulating film.

Abstract: A foldable display device includes a display panel which includes a folding area, a first non-folding area disposed adjacent to a first side of the folding area, and a second non-folding area disposed adjacent to a second side of the folding area opposite to the first side of the folding area, and a panel support member which is disposed on a surface of the display panel and in which a plurality of slits extending in a first direction is defined. The panel support member includes a first layer which has a first fiber yarn extending in a second direction intersecting the first direction, a second layer which has a second fiber yarn extending in the first direction, and a third layer which has a third fiber yarn extending in the second direction.

Abstract: The present disclosure relates to a novel protein variant having an activity of exporting 5?-inosine monophosphate, a microorganism comprising the protein variant, and a method for preparing 5?-inosine monophosphate using the microorganism.

Abstract: The present invention relates to a method for providing a correction alarm in a continuous biometric information measurement system and, more particularly, to a correction alarm method comprising: calculating the next correction time on the basis of an actual correction time of a user, thereby informing the user of the next correction time calculated on the basis of the actual correction time even if correction is performed differently from that of a preset correction period; and dividing a total use period of time of a sensor into a plurality of correction sections and differently calculating the next correction time on the basis of a correction section, to which a time at which an actual reference biometric value is input belongs, from among the plurality of correction sections, so as to use a reference biometric value input at every correction time, thereby accurately correcting a biometric value.

Abstract: The present disclosure relates to a negative electrode for a lithium secondary battery, a method for manufacturing the negative electrode, and the lithium secondary battery including the negative electrode. The negative electrode can include a negative electrode current collector layer, a silicon-based negative electrode active material layer provided on at least one surface of the negative electrode current collector layer, and a ceramic layer provided on a surface of the silicon-based negative electrode active material layer opposite to a surface of the negative electrode active material layer facing the negative electrode current collector layer. The ceramic layer can include a ceramic layer composition or a dried product thereof, and the ceramic layer composition can include ceramic and a binder. BaTiO3 can be included in an amount of 10 parts by weight or more and 50 parts by weight or less based on 100 parts by weight of the ceramic.

Abstract: The present invention relates to a lithium secondary battery which includes a positive electrode, a negative electrode, a separator disposed between the positive electrode and the negative electrode, and an electrolyte solution, wherein a patterned gel polymer electrolyte layer is included on one surface or both surfaces of at least one structure of the positive electrode, the negative electrode, or the separator.

Abstract: Disclosed is an electrochemical device separator and an electrochemical device including the same. The separator includes a porous polymer substrate and a porous organic/inorganic composite coating layer formed on at least one surface of the polymer substrate, in which the porous coating layer includes particulate binder resins and inorganic particles, and [content of binder particles in an upper portion of a porous coating layer before impregnation with electrolyte/content of binder particles in a central portion of a porous coating layer before impregnation with electrolyte]?[content of binder particles in an upper portion of a porous coating layer after impregnation with electrolyte/content of binder particles in a central portion of a porous coating layer after impregnation with electrolyte] is 0.32 or less.

Abstract: An electrochemical device separator including a porous polymer substrate and a porous organic/inorganic composite coating layer on at least one surface of the porous polymer substrate. The porous organic/inorganic composite coating layer includes particulate binder polymers, a non-particulate acrylic-containing polymer, and first inorganic particles. The particulate binder polymers include hybrid polymer particles including a fluorine-containing polymer and an acrylic-containing polymer, and acrylic-containing polymer particles. The acrylic-containing polymer particles have a particle size D50 (a) in a range of 1 ?m to 7 ?m, the first inorganic particles have a particle size D50 (b) in a range of 200 nm to 800 nm, a/b is in a range of 2 to 15, and hybrid polymer particles have a particle size D50 less than 250 nm.

Abstract: The present invention relates to a method for correcting biometric signals in a continuous biometric information measurement system and, more specifically, to a method which, if a correction parameter is unstable when a correction factor is being calculated using a reference biometric value, does not use the current correction factor calculated from a reference biometric value as-is, but revises the current correction factor by applying, to the current correction factor, a compensation value calculated from the difference between the current correction factor and a previous correction factor, and thus even if a correction parameter is unstable it is possible to calculate a corrected biometric value by accurately correcting a biometric signal.